Now Reading
MilliporeSigma Partners With Sterilis Solutions and Pure Strategies To Provide Customers a Way To Reduce the Volume and Environmental Impact of Plastics
MilliporeSigma Partners With Sterilis Solutions and Pure Strategies To Provide Customers a Way To Reduce the Volume and Environmental Impact of Plastics
Published 05-03-24
Submitted by MilliporeSigma
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, Sterilis Solutions, and Pure Strategies have collaborated to address the life science industry's approach to single-use plastic waste. Developed by Sterilis, the Remediator is a device that transforms bio-hazardous waste into non-hazardous plastic shred, paving the way for potential lab recycling and reducing the adverse impacts of traditional disposal methods.
MilliporeSigma partnered with Pure Strategies, a third-party sustainability consulting firm, to complete a Life Cycle Assessment (LCA) and evaluate the environmental benefits and impacts of waste processed via the Remediator versus typical bio-hazardous waste treatment and disposal. The LCA revealed a 95% reduction in carbon emissions and 90% reduction in energy demand while using the Remediator compared to a traditional autoclave.
This strategic collaboration works towards finding circular solutions that reduce the overall volume of petro-virgin plastic and minimizing the environmental impact of plastic waste disposal.
Click here to view the full article on Pure Strategies’ website.
MilliporeSigma
MilliporeSigma
We holistically integrate sustainability throughout our own operations and across suppliers, reducing the impact of scientific research globally and exceeding customer expectations.
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 26,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
Around 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
More from MilliporeSigma
